While phospho-ATM-NEMO-AKT-mTOR signalosome provides growth advantage and treatment resistance to cancer cells [265], from an immunological perspective, re-activation of AKT can support anti-tumor functional activity of T cells. The gene discussed is AKT1; the disease is cancer.